Back to CVE records
Medium 5.3Published Oct 16, 2026

CVE-2026-111237Ultralytics FastSAM AutoBackend Model Loading autobackend.py session.get_modelmeta.custom_metadata_map eval injection

Updated under an hour ago ()

Does this affect you?

It affects Ultralytics FastSAM. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A weakness has been identified in Ultralytics FastSAM up to b4ed20c2fed75eadc5aa7d8b09fedd137b873b52. This affects the function session.get_modelmeta.custom_metadata_map of the file ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. This manipulation of the argument imgsz/names/kpt_shape causes improper neutralization of directives in dynamically evaluated code. The attack requires local access. This product uses a rolling release model to deliver continuous updates. As a result, specific version information for affected or updated releases is not available. The project was informed of the problem early through an issue report but has not responded yet.

CVSS
5.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L/E:X/RL:X/RC:C
Weakness (CWE)
CWE-95, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Oct 16, 2026
First seen by InfoSec Signals
Oct 16, 2026

Affected products

Affected products
Ultralytics FastSAM
ultralytics:fastsam
b4ed20c2fed75eadc5aa7d8b09fedd137b873b52
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • issue-tracking

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.